Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.
Iwakiri K, Fujiwara Y, Manabe N, Ihara E, Kuribayashi S, Akiyama J, Kondo T, Yamashita H, Ishimura N, Kitasako Y, Iijima K, Koike T, Omura N, Nomura T, Kawamura O, Ohara S, Ozawa S, Kinoshita Y, Mochida S, Enomoto N, Shimosegawa T, Koike K. Iwakiri K, et al. Among authors: manabe n. J Gastroenterol. 2022 Apr;57(4):267-285. doi: 10.1007/s00535-022-01861-z. Epub 2022 Feb 28. J Gastroenterol. 2022. PMID: 35226174 Free PMC article. Review.
Validity of endoscopic classification of nonerosive reflux disease.
Joh T, Miwa H, Higuchi K, Shimatani T, Manabe N, Adachi K, Wada T, Sasaki M, Fujiwara Y, Hongo M, Chiba T, Kinoshita Y; ARS Research Group. Joh T, et al. Among authors: manabe n. J Gastroenterol. 2007 Jun;42(6):444-9. doi: 10.1007/s00535-007-2022-3. Epub 2007 Jun 29. J Gastroenterol. 2007. PMID: 17671758
It is possible to classify non-erosive reflux disease (NERD) patients into endoscopically normal groups and minimal change groups by subjective symptoms and responsiveness to rabeprazole -- a report from a study with Japanese patients.
Kusano M, Shirai N, Yamaguchi K, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom (ARS) Research Group. Kusano M, et al. Dig Dis Sci. 2008 Dec;53(12):3082-94. doi: 10.1007/s10620-008-0290-2. Epub 2008 May 9. Dig Dis Sci. 2008. PMID: 18465242 Clinical Trial.
Does magnifying endoscopy improve the diagnosis of erosive esophagitis?
Amano Y, Yamashita H, Koshino K, Ohshima T, Miwa H, Iwakiri R, Fujimoto K, Manabe N, Haruma K, Kinoshita Y. Amano Y, et al. Among authors: manabe n. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1063-8. doi: 10.1111/j.1440-1746.2008.05453.x. Epub 2008 Jun 28. J Gastroenterol Hepatol. 2008. PMID: 18554240
Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.
Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, Shimatani T, Adachi K, Kinjo F, Kuribayashi S, Mitsufuji S, Fujiwara Y, Koyama S, Akiyama J, Takagi A, Manabe N, Miwa H, Shimoyama Y, Kusano M. Danjo A, et al. Among authors: manabe n. J Gastroenterol Hepatol. 2009 Apr;24(4):633-8. doi: 10.1111/j.1440-1746.2008.05747.x. Epub 2009 Jan 12. J Gastroenterol Hepatol. 2009. PMID: 19220681
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
Ashida K, Kinoshita Y, Hongo M; Japan Rabeprazole Study Group for NERD. Ashida K, et al. Dig Dis Sci. 2011 Aug;56(8):2333-42. doi: 10.1007/s10620-011-1583-4. Epub 2011 Feb 8. Dig Dis Sci. 2011. PMID: 21302138 Clinical Trial.
Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.
Furuta T, Shimatani T, Sugimoto M, Ishihara S, Fujiwara Y, Kusano M, Koike T, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom Research Group. Furuta T, et al. J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24. J Gastroenterol. 2011. PMID: 21861141 Clinical Trial.
Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
Shimatani T, Sugimoto M, Nishino M, Adachi K, Furuta K, Ito M, Kurosawa S, Manabe N, Mannen K, Hongo M, Chiba T, Kinoshita Y; Acid-Related Symptom Research (ARS) Group. Shimatani T, et al. Among authors: manabe n. J Gastroenterol Hepatol. 2012 May;27(5):899-906. doi: 10.1111/j.1440-1746.2011.06975.x. J Gastroenterol Hepatol. 2012. PMID: 22098590 Clinical Trial.
438 results